These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 18467505)
1. Gene therapy of Cav1.2 channel with VIP and VIP receptor agonists and antagonists: a novel approach to designing promotility and antimotility agents. Shi XZ; Sarna SK Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G187-G196. PubMed ID: 18467505 [TBL] [Abstract][Full Text] [Related]
2. Homeostatic and therapeutic roles of VIP in smooth muscle function: myo-neuroimmune interactions. Shi XZ; Sarna SK Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G716-25. PubMed ID: 19661154 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart. Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371 [TBL] [Abstract][Full Text] [Related]
5. Gene plasticity in colonic circular smooth muscle cells underlies motility dysfunction in a model of postinfective IBS. Choudhury BK; Shi XZ; Sarna SK Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G632-42. PubMed ID: 19136376 [TBL] [Abstract][Full Text] [Related]
6. In silico classification and prediction of VIP derivatives as VPAC1/ VPAC2 receptor agonists/antagonists. Li J; Wang X; Liu H; Li H Comb Chem High Throughput Screen; 2015; 18(1):33-41. PubMed ID: 25438751 [TBL] [Abstract][Full Text] [Related]
7. A novel role of VIP in colonic motility function: induction of excitation-transcription coupling in smooth muscle cells. Shi XZ; Choudhury BK; Pasricha PJ; Sarna SK Gastroenterology; 2007 Apr; 132(4):1388-400. PubMed ID: 17408637 [TBL] [Abstract][Full Text] [Related]
8. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation. St Hilaire RC; Murthy SN; Kadowitz PJ; Jeter JR Peptides; 2010 Aug; 31(8):1517-22. PubMed ID: 20452385 [TBL] [Abstract][Full Text] [Related]
9. Alterations in the relative abundance of the vasoactive intestinal peptide receptors (VPAC1 and VPAC2) and functions in uterine contractility during inflammation. Palus K; Całka J; Jana B Anim Reprod Sci; 2021 Feb; 225():106680. PubMed ID: 33388613 [TBL] [Abstract][Full Text] [Related]
10. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
11. [Effect of vasoactive intestinal peptide on the motility of guinea-pig colon in vitro]. Ishizawa M Nihon Heikatsukin Gakkai Zasshi; 1988 Jun; 24(3):185-92. PubMed ID: 3246807 [TBL] [Abstract][Full Text] [Related]
12. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors. Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659 [TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons. Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242 [TBL] [Abstract][Full Text] [Related]
14. Norepinephrine mediates the transcriptional effects of heterotypic chronic stress on colonic motor function. Choudhury BK; Shi XZ; Sarna SK Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1238-47. PubMed ID: 19359422 [TBL] [Abstract][Full Text] [Related]
15. Negative transcriptional regulation of human colonic smooth muscle Cav1.2 channels by p50 and p65 subunits of nuclear factor-kappaB. Shi XZ; Pazdrak K; Saada N; Dai B; Palade P; Sarna SK Gastroenterology; 2005 Nov; 129(5):1518-32. PubMed ID: 16285952 [TBL] [Abstract][Full Text] [Related]
16. Characterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouse. Ekblad E; Jongsma H; Brabet P; Bockaert J; Sundler F Ann N Y Acad Sci; 2000; 921():137-47. PubMed ID: 11193817 [TBL] [Abstract][Full Text] [Related]
17. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production. Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701 [TBL] [Abstract][Full Text] [Related]
18. Effect of VIP on intracellular [Ca2+], extracellular regulated kinase 1/2, and secretion in cultured rat conjunctival goblet cells. Li D; Jiao J; Shatos MA; Hodges RR; Dartt DA Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2872-84. PubMed ID: 23518767 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383 [TBL] [Abstract][Full Text] [Related]
20. Role of VPAC2 receptor in monocrotaline-induced pulmonary hypertension in rats. Koga M; Mizuno Y; Watanabe I; Kawakami H; Goto T J Appl Physiol (1985); 2014 Aug; 117(4):383-91. PubMed ID: 24947028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]